Prognostic usefulness of metabolic syndrome compared with diabetes in Korean patients with critical lower limb ischemia treated with percutaneous transluminal angioplasty

Yonsei Medical Journal

Volumn 55, Issue 1, 2014, Pages 46-52

  Won, Ki Bum ^a   Chang, Hyuk Jae ^b   Hong, Sung Jin ^b   Ko, Young Guk ^b   Hong, Myeong Ki ^b   Jang, Yangsoo ^b   Choi, Donghoon ^b  

^a Hanyang Medical Center   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Angioplasty; Critical limb ischemia; Diabetes; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; HEPARIN; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BALLOON CATHETER; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; EMBOLISM; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; GUIDE WIRE; HUMAN; HYPERTENSION; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROGNOSIS; RETROSPECTIVE STUDY; RUPTURE; STENOSIS; TREATMENT OUTCOME; VASCULAR PATENCY;

ANGIOPLASTY; CRITICAL LIMB ISCHEMIA; DIABETES; METABOLIC SYNDROME;

AGED; AGED, 80 AND OVER; ANGIOPLASTY; DIABETES MELLITUS; FEMALE; HUMANS; ISCHEMIA; LOWER EXTREMITY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES;

EID: 84890588552     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2014.55.1.46     Document Type: Article

References (24)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
2. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112: 2735-52.
3. Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002;25:1790-4.
4. Nakanishi N, Takatorige T, Fukuda H, Shirai K, Li W, Okamoto M, et al. Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Diabetes Res Clin Pract 2004;64:59-70.
5. Simmons RK, Alberti KG, Gale EA, Colagiuri S, Tuomilehto J, Qiao Q, et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 2010; 53:600-5.
6. Long-term mortality and its predictors in patients with critical leg ischaemia. The I.C.A.I. Group (Gruppo di Studio dell'Ischemia Cronica Critica degli Arti Inferiori). The Study Group of Criticial Chronic Ischemia of the Lower Exremities. Eur J Vasc Endovasc Surg 1997;14:91-5.
7. Hanna GP, Fujise K, Kjellgren O, Feld S, Fife C, Schroth G, et al. Infrapopliteal transcatheter interventions for limb salvage in diabetic patients: importance of aggressive interventional approach and role of transcutaneous oximetry. J Am Coll Cardiol 1997;30: 664-9.
8. West KW. Epidemiology of diabetes and its vascular complications: Report to U.S. National Commission on Diabetes. Scope Impact Diabetes 1975;3:56-60.
9. Cheng SW, Ting AC, Lau H, Wong J. Survival in patients with chronic lower extremity ischemia: a risk factor analysis. Ann Vasc Surg 2000;14:158-65.
10. Koehler C, Ott P, Benke I, Hanefeld M; DIG Study Group. Comparison of the prevalence of the metabolic syndrome by WHO, AHA/NHLBI, and IDF definitions in a German population with type 2 diabetes: the Diabetes in Germany (DIG) Study. Horm Metab Res 2007;39:632-5.
11. Alexander CM, Landsman PB, Teutsch SM, Haffner SM; Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003;52:1210-4.
12. Tong PC, Kong AP, So WY, Yang X, Ho CS, Ma RC, et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 2007;30: 1206-11.
13. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517-38.
14. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-47.
15. Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won Yoon J, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 2011;34:1323-8.
16. Gupta AK, Prieto-Merino D, Dahlöf B, Sever PS, Poulter NR; ASCOT Investigators. Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT-BPLA: comparison of their relative predictability using a novel approach. Diabet Med 2011;28:941-7.
17. Stern MP, Williams K, González-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 2004;27:2676-81.
18. Won KB, Chang HJ, Kim HC, Jeon K, Lee H, Shin S, et al. Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes. Cardiovasc Diabetol 2013;12:41.
19. Larsen JR, Brekke M, Bergengen L, Sandvik L, Arnesen H, Hanssen KF, et al. Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes. Diabetologia 2005;48:776-9.
20. Sander D, Schulze-Horn C, Bickel H, Gnahn H, Bartels E, Conrad B. Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis: the INVADE study. Stroke 2006;37:351-7.
21. Faglia E, Dalla Paola L, Clerici G, Clerissi J, Graziani L, Fusaro M, et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg 2005; 29:620-7.
22. Ferraresi R, Centola M, Ferlini M, Da Ros R, Caravaggi C, Assaloni R, et al. Long-term outcomes after angioplasty of isolated, below-the-knee arteries in diabetic patients with critical limb ischaemia. Eur J Vasc Endovasc Surg 2009;37:336-42.
23. Hwang MJ, Chung WS, Gallagher D, Kim DY, Shin HD, Song MY. How useful is waist circumference for assessment of abdominal obesity in Korean pre-menopausal women during weight loss? Asia Pac J Clin Nutr 2008;17:229-34.
24. Gurka MJ, Ice CL, Sun SS, Deboer MD. A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences. Cardiovasc Diabetol 2012;11:128.